Relaxin remodels fibrotic healing following myocardial infarction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Relaxin remodels fibrotic healing following myocardial infarction

Published:2011-01-10 Issue:5 Volume:91 Page:675-690
ISSN:0023-6837
Container-title:Laboratory Investigation
language:en
Short-container-title:Lab Invest

Author:

Samuel Chrishan S,Cendrawan Sofia,Gao Xiao-Ming,Ming Ziqiu,Zhao Chongxin,Kiriazis Helen,Xu Qi,Tregear Geoffrey W,Bathgate Ross A D,Du Xiao-Jun

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

http://www.nature.com/articles/labinvest2010198.pdf

Reference42 articles.

1. See F, Kompa A, Martin J, et al. Fibrosis as a therapeutic target post-myocardial infarction. Curr Pharm Des 2005;11:477–487.

2. Jugdutt BI . Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways. Curr Drug Targets Cardiovasc Haematol Disord 2003;3:1–30.

3. Braunwald E, Bristow MR . Congestive heart failure: fifty years of progress. Circulation 2000;102:IV14–IV23.

4. Sun Y, Weber KT . Infarct scar: a dynamic tissue. Cardiovasc Res 2000;46:250–256.

5. Lu L, Zhang JQ, Ramires FJ, et al. Molecular and cellular events at the site of myocardial infarction: from the perspective of rebuilding myocardial tissue. Biochem Biophys Res Commun 2004;320:907–913.

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of relaxin or relaxin mimetics in managing cardiovascular complications of diabetes;Biochemical Pharmacology;2024-11

2. Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology;Biochemical Pharmacology;2024-09

3. Cardiomyocyte-specific RXFP1 overexpression protects against pressure overload-induced cardiac dysfunction independently of relaxin;Biochemical Pharmacology;2024-07

4. The involvement of the Wnt/β-catenin signaling cascade in fibrosis progression and its therapeutic targeting by relaxin;Biochemical Pharmacology;2024-05

5. Step-by-step fabrication of heart-on-chip systems as models for cardiac disease modeling and drug screening;Talanta;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3